The study and its comparison
One hundred twenty-six adults with mild-to-moderate depressive symptoms entered the study; 112 provided analyzable data. Six weeks of magnesium chloride supplying 248 milligrams of elemental magnesium were compared with six weeks without treatment. [1]
Depression and anxiety scores improved during the magnesium period. Participants knew whether they were taking the supplement, so expectation and reporting effects could contribute. [1]
What the finding establishes
Randomization does not remove every limitation of an unblinded design. The study is not a comprehensive interaction assessment for antidepressants or evidence to replace them. Its duration cannot establish long-term safety. The authors declared no competing interests; funding was not established from the retrieved record. A positive signal warrants a blinded comparison. [1]
A hypothetical distinction
Imagine participants know when active treatment begins. That knowledge can affect symptom ratings even when the order was randomized.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Role of magnesium supplementation in the treatment of depression: A randomized clinical trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.